HF1269 (Legislative Session 94 (2025-2026))
Coverage of medical services and prescription medications for the treatment of dementia required, and step therapy requirements for medical assistance modified.
Related bill: SF1998
AI Generated Summary
Purpose
- Require health plan companies to cover all FDA-approved medical services and prescription medications used to treat or slow the progression of dementia.
- Require coverage for diagnostic testing to determine whether a medical service or medication is appropriate or effective for treating or slowing dementia.
- Prohibit the use of step therapy protocols when providing this dementia coverage.
Main Provisions
- Coverage scope: Health plans must cover every FDA-approved medical service and prescription medication used to treat or slow dementia, as well as related diagnostic tests to assess appropriateness or effectiveness.
- Step therapy ban: Health plans may not apply step therapy (a process that requires trying less expensive or fewer-risk options before more costly or newer treatments) for the dementia-related services and medications described.
- Legal amendments: Makes changes to Minnesota Statutes, including amending section 256B.0625 subdivision 13f and adding new provisions in Minnesota Statutes chapter 62Q (specifically 62Q.546).
Significant Changes to Existing Law
- Broadens required coverage for dementia care by mandating FDA-approved treatments and associated diagnostic testing.
- Restricts the use of step therapy for dementia treatments, limiting insurers’ ability to delay or deny access to dementia therapies.
- Introduces a new statutory provision (62Q.546) to codify these dementia coverage requirements and related protections.
Potential Impacts and Considerations
- Access: Aims to reduce barriers to dementia treatment by ensuring comprehensive coverage and timely access to therapeutics and diagnostics.
- Costs: May affect premium levels and insurer budgeting due to broader coverage requirements.
- Scope: Applies to dementia treatments approved by the FDA; does not mention non-FDA-approved or experimental therapies.
Relevant Terms dementia, FDA-approved, medical services, prescription medications, diagnostic testing, coverage, health plan company, step therapy, step therapy protocol, 62Q.184 subdivision 1, 62Q.546, Minnesota Statutes, 256B.0625 subdivision 13f, medical assistance
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| February 20, 2025 | House | Action | Introduction and first reading, referred to | Commerce Finance and Policy | |
| February 24, 2025 | House | Action | Author added | ||
| February 26, 2025 | House | Action | Author added | ||
| March 05, 2025 | House | Action | Author added | ||
| March 06, 2025 | House | Action | Authors added | ||
| March 12, 2025 | House | Action | Author added | ||
| March 13, 2025 | House | Action | Author added | ||
| March 17, 2025 | House | Action | Author added | ||
| April 01, 2025 | House | Action | Author added | ||
| March 12, 2026 | House | Action | Authors added | ||
| March 16, 2026 | House | Action | Author added | ||
| March 18, 2026 | House | Action | Authors added |
Citations
[
{
"analysis": {
"added": [
"Adds requirements that health plans cover dementia-related medical services and FDA-approved prescription medications used to treat or slow progression of dementia.",
"Requires coverage of diagnostic testing to determine the appropriateness or effectiveness of dementia-related medical services or medications."
],
"removed": [],
"summary": "This bill amends Minnesota Statutes 2024 section 256B.0625, subdivision 13f, to require health plans/medical assistance coverage for dementia-related medical services and FDA-approved medications, and to ensure diagnostic testing is covered to assess treatment appropriateness or effectiveness.",
"modified": [
"Incorporates a prohibition on the use of step therapy for dementia coverage by referencing 62Q.184, subdivision 1."
]
},
"citation": "256B.0625",
"subdivision": "13f"
},
{
"analysis": {
"added": [],
"removed": [],
"summary": "Defines the step therapy protocol in 62Q.184, subdivision 1, which the bill references to prohibit its use in dementia coverage.",
"modified": [
"Applied to dementia coverage by prohibiting the use of the defined step therapy when providing dementia-related coverage."
]
},
"citation": "62Q.184",
"subdivision": "1"
},
{
"analysis": {
"added": [],
"removed": [],
"summary": "References Minnesota Statutes chapter 62Q as the governing chapter for the bill's step therapy provisions related to dementia coverage.",
"modified": []
},
"citation": "62Q",
"subdivision": ""
}
]Progress through the legislative process
In Committee
Sponsors
- Rep. Lucille Rehm (DFL)
- Rep. Patty Acomb (DFL)
- Rep. Esther Agbaje (DFL)
- Rep. Patti Anderson (R)
- Rep. Kaela Berg (DFL)
- Rep. Robert Bierman (DFL)
- Rep. Brion Curran (DFL)
- Rep. Gregory Davids (R)
- Rep. Peter Fischer (DFL)
- Rep. Mike Freiberg (DFL)
- Rep. Rick Hansen (DFL)
- Rep. Amanda Hemmingsen-Jaeger (DFL)
- Rep. Kaohly Her (DFL)
- Rep. Huldah Hiltsley (DFL)
- Rep. Kristi Pursell (DFL)
- Rep. Liz Reyer (DFL)
- Rep. John Huot (DFL)
- Rep. Peter Johnson (DFL)
- Rep. Carlie Kotyza-Witthuhn (DFL)
- Rep. Jon Koznick (R)
- Rep. Larry Kraft (DFL)
- Rep. Andrew Smith (DFL)
- Rep. Zack Stephenson (DFL)
- Rep. Bianca Virnig (DFL)
- Rep. Cheryl Youakim (DFL)
- Rep. Kristin Bahner (DFL)
- Rep. Mary Frances Clardy (DFL)
- Rep. Alexander Falconer (DFL)
- Rep. Kelly Moller (DFL)
- Rep. Matt Norris (DFL)
- Rep. María Isa Pérez-Vega (DFL)